Hester Biosciences Ltd — Major Shareholding Notification 2021

Apr 7, 2021

From RAJIV GANDHI B-3, 399 Apartment, Near Nehru Foundation, Bodakdev, Ahmedabad 380 054

Date: 02.04.2021

To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 524669

To, National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051 Symbol: HESTERBIO

Dear Sir / Madam:

Subject: Disclosure under Regulations 30 (1) & 30 (2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Pursuant to Regulation 30(1) & 30 (2) of the SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011, on behalf of the promoters of the Hester Biosciences Limited as defined in Regulation 2 (i) (s) of the said Regulations and hereby inform that as on 31.03.2021, my holding together with other promoters and promoters group was 45,70,944 Equity Shares of the Hester Biosciences Limited i.e. 53.73% of the total Paid-up Equity Capital.

Kindly find enclosed Disclosure under Regulations 30(1) & 30(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, in the prescribed format as in annexure.

Sincerely,

==> picture [42 x 44] intentionally omitted <==

(Rajiv Gandhi)

Enclosure: As above

CC TO:

To The Company Secretary & Compliance Officer Hester Biosciences Limited 1[st] Floor, Pushpak, Panchavati Circle, Motilal Hirabhai Road, Ahmedabad – 380 006

Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Part-A- Details of Shareholding:

Part-A- Details of Shareholding:
1. Name of the Target Company (TC)	HESTER BIOSCIENCES LIMITED
2. Name(s) of the Stock Exchange(s) where the shares of the TC are listed	BSE Limited; National Stock Exchange of India Limited
3. Particulars of the shareholder(s): a. Name of person(s) together with Persons Acting in Concert (PAC) whose total holding (including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the target company) is more than 25% of the voting rights of the TC. Or b. Name(s) of promoter(s), member of the promoter group and Persons Acting in Concert (PAC) with him.	Not Applicable As per Annexure - 1 (attached herewith)
4. Particulars of the Shareholding of persons mentioned at (3) above	Number of Shares	% w. r. t. total share /voting capital wherever applicable	% of total diluted share/voting capital of TC (*)
As of 31.03.2021, holding of: a. Shares b. Voting Rights (otherwise than by shares) c. Warrants, d. Convertible Securities e. Any other instrument that would entitle the holder to receive shares in the TC.	45,70,944 - - - -	53.73 - - - -	53.73 - - - -
Total	45,70,944	53.73	53.73

==> picture [42 x 43] intentionally omitted <==

---

(Rajiv Gandhi)

Place: Ahmedabad Date: 02.04.2021

Part-B**

Name of the Target Company: HESTER BIOSCIENCES LIMITED

Name of the Target Company:HESTER	BIOSCIENCES LIMI	TED
Name(s) of the acquirer and Persons Acting in Concert (PAC) with the acquirer	Whether the acquirer belongs to Promoter/ Promoter group	PAN of the acquirer and/ or PACs
Mr. Rajiv Dinesh Gandhi	Yes
Ms. Nina Rajiv Gandhi	Yes
Mr. Sanjiv Dinesh Gandhi	Yes
Mr. Ravin Gandhi	Yes
Ms. Bela Gandhi	Yes
Dr. Bhupendra Vittaldas Gandhi	Yes
Bhupendra Vittaldas Gandhi HUF	Yes
Ms. Shaila Bhupendra Gandhi	Yes
Mr. Anup Chandravadan Kapadia	Yes
Ms. Hetal Sanjiv Gandhi	Yes
Mr. Yash Rajiv Gandhi	Yes
Biolink Healthcare Limited	Yes
Hester Diagnostics Private Limited	Yes
Hester Coatings LLP	Yes

==> picture [41 x 43] intentionally omitted <==

_____

(Rajiv Gandhi)

Place: Ahmedabad Date: 02.04.2021

Note:

1. In case of promoter(s) making disclosure under regulation 30(2), no additional disclosure under regulation 30(1) is required.

2. (*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

3. (**) Part-B shall be disclosed to the Stock Exchanges but shall not be disseminated.

ANNEXURE – 1

SHAREHOLDING OF PROMOTERS AND PROMOTERS GROUP AS ON 31.03.2021

Name of Promoters	Number of Shares held	% of holding
Mr. Rajiv Dinesh Gandhi	8,90,397	10.47
Ms. Nina Rajiv Gandhi	6,96,340	8.19
Mr. Sanjiv Dinesh Gandhi	6,97,820	8.20
Mr. Ravin Gandhi	4,03,320	4.74
Ms. Bela Gandhi	4,00,635	4.71
Dr. Bhupendra Vithaldas Gandhi	3,99,100	4.69
Bhupendra Vithaldas Gandhi HUF	3,01,600	3.55
Biolink Healthcare Limited	2,48,838	2.93
Mr. AnupChandravadan Kapadia	2,28,354	2.68
Ms. Shaila Bhupendra Gandhi	1,89,700	2.23
Hester Coatings LLP	64,000	0.75
Hester Diagnostics Private Limited	24,000	0.28
Ms. Hetal Sanjiv Gandhi	19,590	0.23
Mr. Yash Rajiv Gandhi	7,250	0.08
Total	45,70,944	53.73

==> picture [41 x 44] intentionally omitted <==

_____ (Rajiv Gandhi)

Place: Ahmedabad Date: 02.04.2021